CliniSonix Technology Development

1. Our primary mandate at API is to advance basic research and innovation to commercialization by providing access to world-class industry expertise, services, and infrastructure. Our activities focuses on engaging and supporting drug discovery and development initiatives, ensuring compliance with regulatory standards and driving innovation and commercialization through collaborative research and clinical studies.
2. The project will address specific challenges including development of improved 3D ultrasound technology. It aims to reduce development timelines by leveraging interdisciplinary collaboration and intern support while addressing talent gaps through hands-on training.
3.This social and economic benefit of the project is vast. Specifically, it will accelerate innovative ultrasound system development, reduces costs, enhances patient outcomes, and strengthens market leadership. It will also address workforce gaps by training skilled interns, boosting talent pipelines. These benefits drive sustainable growth, improve healthcare, and position our client as a leader in advanced ultrasound technology

Faculty Supervisor:

Roger James Zemp

Student:

Partner:

Applied Pharmaceutical Innovation

Discipline:

Engineering

Sector:

Professional, scientific and technical services; Retail trade

University:

University of Alberta

Program: